ATS: Clinical Practice Guidelines on the Pharmacologic Management of COPD
The American Thoracic Society has released a new clinical practice guideline on the pharmacologic management of chronic obstructive pulmonary disease.
Chronic Obstructive Pulmonary Disease
Perrigo Recalls All Albuterol Sulfate Inhalers
To date, Perrigo has received several thousand complaints related to their product.
Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life
Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.
Acute COPD Exacerbation Frequency May Not Be Accurate Guide for Treatment
The 12-month history of acute exacerbations used to guide most COPD treatment relies on an unstable frequent exacerbator phenotype.
Late Life Disability Instrument Can Assess Life Role Participation in COPD
In patients with COPD, the Late Life Disability Instrument demonstrated test-retest reliability, internal consistency, and construct and face validity.
HRRP Implementation Reduced 30-Day All-Cause Readmission Rates in COPD
Implementation of the Hospital Readmission Reduction Program was associated with a decrease in 30-day readmissions in patients with COPD following their hospital discharge.
Vascular Calcification in COPD Affects Bone Mineral Density, Increases Fractures
Researchers evaluated the association between osteoporosis and vertebral fragility fractures with cardiovascular calcification in patients with chronic obstructive pulmonary disease.
Lung DNA Methylation in COPD May Differ by Smoking Status, Airflow Limitation
Bronchoalveolar lavage appears to be safe and well tolerated in individuals with idiopathic pulmonary fibrosis.
Oral Sustained-Release Morphine May Improve Moderate, Severe Breathlessness in COPD
The use of regular, low-dose, oral sustained-release morphine for 4 weeks in patients with COPD and moderate to very severe breathlessness has been shown to improve disease-specific health status.
Interstitial Lung Abnormalities Linked to Clinical Course in COPD
In patients with COPD, interstitial lung abnormalities are significantly associated with moderate to severe acute disease exacerbations and with an accelerated decline in lung function.
-
Loading...
-
Loading...
